FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje et al.
N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Jung, Carina; Fichter, Michael; Oberlaender, Jennifer et al.
Nanobodies Outperform Antibodies - Rapid Functionalization with Equal In Vivo Targeting PropertiesADVANCED MATERIALS. Bd. 36. H. 52. 2024
Schafer, Gabriela; Bi, Dongdong; Fenaroli, Federico et al.
Nanoparticles Combining Host-Directed Therapeutics and Antibiotics to Boost Bacterial Killing and Overall Survival of Zebrafish Embryos Infected with <i>Mycobacterium Marinum</i>ADVANCED THERAPEUTICS. Bd. 8. H. 4. 2024
Hewel, Charlotte; Schmidt, Hanno; Runkel, Stefan et al.
Nanopore adaptive sampling of a metagenomic sample derived from a human monkeypox caseJOURNAL OF MEDICAL VIROLOGY. Bd. 96. H. 5. 2024
Pastore, Stefan; Wierczeiko, Anna; Mundnich, Stefan et al.
NanopoReaTA: Real-Time RNA-Sequencing Analysis for time-efficient Decision-MakingEUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 32. 2024 S. 1626-1626
Kechagioglou, Petros; Chakraborty, Debomita; Dupont, Camille et al.
Narazaciclib's differential targets and kinase inhibitory activity contribute to the enhanced inhibition of tumor growth in preclinical modelsCANCER RESEARCH. Bd. 84. H. 9. 2024
Bork, Francesca; Greve, Carsten L.; Youn, Christine et al.
naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammationEMBO REPORTS. Bd. 25. H. 7. 2024 S. 2914-2949
Mattos, Matheus Silverio; Vandendriessche, So fie; Schuermans, Sara et al.
Natural antibodies are required for clearance of necrotic cells and recovery from acute liver injuryJHEP REPORTS. Bd. 6. H. 4. 2024
Kampmann, Christoph; Lampe, Christina; Wiethoff, Christiane M. et al.
Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapyJOURNAL OF INHERITED METABOLIC DISEASE. Bd. 48. H. 1. 2024
Mora, Jaume; Chan, Godfrey C.; Morgenstern, Daniel A. et al.
Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024